Blossomhill Therapeutics, Inc. (BLSM)
13.94
-1.04
(-6.94%)
USD |
NASDAQ |
Oct 16, 16:00
14.03
+0.09
(+0.65%)
After-Hours: 20:00
Blossomhill Therapeutics Debt to Equity Ratio : -1.603 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.603 |
| Date | Value |
|---|---|
| March 31, 2026 | -1.840 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| IGC Pharma, Inc. | 0.1765 |
| Cocrystal Pharma, Inc. | 1.284 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| Arvinas, Inc. | 0.0146 |
| Fulcrum Therapeutics, Inc. | 0.017 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 124.13M |
| Total Liabilities (Quarterly) | 298.91M |
| Shareholders Equity (Quarterly) | -174.78M |
| Current Ratio | 5.261 |